CNS Disorders  >>  buprenorphine/naloxone sublingual film 
Welcome,         Profile    Billing    Logout  

6 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
buprenorphine/naloxone sublingual film / Generic mfg.
2021-001817-35: Treatment of opioid dependency in patients with chronic pain: a comparative study between suboxone and methadone. Behandeling van opiaatafhankelijkheid bij pijn: een vergelijkende studie met suboxone en methadon.

Ongoing
4
100
Europe
Methadone, Sublingual tablet, Tablet, Suboxone, Methadone
Radboud University Medical Center, Dutch Research Council (NWO)
Opioid use disorder Stoornis in het opioïdgebruik, Dependence on opioids Afhankelijkheid aan opiaten, Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
YHEROES, NCT04811014: Young Houston Emergency Opioid Engagement System

Recruiting
4
15
US
Buprenorphine, Naloxone Drug Combination, Suboxone, Individual Counseling, Therapy, Peer Recovery Support Services, Peer Coaching, Recovery Coaching, Support Group, Group Therapy, Referral to Medication Management, Assertive Outreach, Community Outreach
The University of Texas Health Science Center, Houston
Opioid-use Disorder, Opioid Dependence, Opioid Overdose, Opioid Use, Substance Use Disorders
08/24
08/27
2018-004460-63: Extended-release Pharmacotherapy for Opioid Use Disorder (EXPO)

Not yet recruiting
3
600
Europe
Sublocade, Buprenorphine, METHADONE, Buprenorphine-Naloxone, Espranor Oral lyophilisate, RBP-6000, Solution for infusion in pre-filled syringe, Sublingual tablet, Oral liquid, Oral lyophilisate, SUBOXONE, Espranor
South London and Maudsley NHS Foundation Trust, King's College London, INDIVIOR UK
Opiod addiction, Opiod Addiction, Psychiatry and Psychology [F] - Mental Disorders [F03]
 
 
MOMs-CMA, NCT03911466: Medication Treatment for Opioid Use Disorder in Expectant Mothers: Conceptual Model Assessments Sub-study

Active, not recruiting
3
97
US
Buprenorphine Injection, CAM2038, Buprenorphine Sublingual Product, Subutex, Suboxone
T. John Winhusen, PhD, National Institute on Drug Abuse (NIDA), The Emmes Company, LLC
Opioid-Related Disorders, Drug Addiction, Pregnancy Related, Substance Abuse, Drug Abuse, Neonatal Abstinence Syndrome, Neonatal Opioid Withdrawal Syndrome, Drug Abuse in Pregnancy
01/25
01/25
MOMs, NCT03918850: Medication Treatment for Opioid Use Disorder in Expectant Mothers

Active, not recruiting
3
140
US
Buprenorphine Injection, CAM2038, Buprenorphine Sublingual Product, Subutex, Suboxone
T. John Winhusen, PhD, National Institute on Drug Abuse (NIDA), The Emmes Company, LLC
Opioid-Related Disorders, Drug Addiction, Pregnancy Related, Substance Abuse, Drug Abuse, Neonatal Abstinence Syndrome, Neonatal Opioid Withdrawal Syndrome, Drug Abuse in Pregnancy
01/25
01/25
MOMs-INO, NCT03911739: Medication Treatment for Opioid Use Disorder in Expectant Mothers: Infant Neurodevelopmental Outcomes Sub-study

Recruiting
3
200
US
Buprenorphine Injection, CAM2038, Buprenorphine Sublingual Product, Subutex, Suboxone
T. John Winhusen, PhD, National Institute on Drug Abuse (NIDA), The Emmes Company, LLC
Opioid-Related Disorders, Drug Addiction, Pregnancy Related, Substance Abuse, Drug Abuse, Neonatal Abstinence Syndrome, Neonatal Opiate Withdrawal Syndrome, Drug Abuse in Pregnancy
01/25
01/25

Download Options